Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased
Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased
In this study, vitamin D deficiency did not correlate to COVID-19 infection rate. COVID-19 mortality was significantly associated with vitamin D deficiency.
The data from this study provides evidence that vitamin D may have an anti‐inflammatory effect on COVID‐19 patients and vitamin D may provide protective effects.
High prevalence of low vitamin D levels is associated with increased disease severity due to an increased immune-inflammatory response.
Though the results are not significant, Serum levels of 25(OH)D, vitamin B12, and especially zinc at the time of admission can affect clinical outcomes in COVID‐19 patients.
Vitamin D deficiency has a significant dose-response relationship with adverse clinical outcomes of COVID-19 infection, including hospitalization and mortality.
Vitamin D levels of healthy children (>6 years old) and adolescents decreased in the first year of the pandemic most likely due to the pandemic-related restrictions.
Vitamin D and COVID-19 Infection Take Home Message Vitamin D deficiency
Does vitamin D serum level affect prognosis of COVID-19 patients? Take Home
Vitamin D deficiency in critically ill COVID-19 ARDS patients Take Home Message